Carney, Macron and Chinese windfarms come under fire
US President Donald Trump gestures as he delivers a special address during the World Economic Forum (WEF) annual…
Number of new U.S. drug shortages hits lowest level in 20 years
The number of ongoing prescription drug shortages rose slightly in the last quarter of 2025, but remained significantly…
J&J wants to be the leader in the cancer fight. Its strategy is starting to pay off as oncology sales top $25 billion in 2025.
Last Updated: Jan. 21, 2026 at 10:14 a.m. ETFirst Published: Jan. 21, 2026 at 7:26 a.m. ET Johnson & Johnson…
Another alliance of health care and AI signals why pharma stocks could be back
Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the…
Novo Nordisk shares rise after Wegovy obesity pill launch
A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, US, on Thursday, Jan.…
Half of GLP-1 users ditch their injections — and some are turning to other weight-loss methods instead
Published: Jan. 15, 2026 at 11:51 a.m. ET Millions of Americans have tried GLP-1s, but some people find that…
$3.3M Trial of Ai-Designed Bacteriophage Therapy for HAP/VAP
Locus Biosciences will conduct a clinical trial for its Ai-designed bacteriophage therapeutic for HAP/VAP caused by antibiotic-resistant P. aeruginosa.…
Johnson & Johnson, U.S. agree on drug discounts, new plants
Key Terms
tariffs
regulatory
Tariffs are taxes imposed by a government on goods…
Kennedy’s SSRI rhetoric fuels distrust amid teen mental health crisis
While his war on vaccines may be getting more attention, health secretary Robert F. Kennedy Jr. is coming…
Opinion: America’s new vaccine doctrine for children replaces data with dogma
Outside the BoxThe Trump administration has dropped recommendations for six vaccines and one preventative therapy for all children…
Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference
TEL AVIV, Israel, Jan. 05, 2026 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today…
First GLP-1 pill for obesity from Novo Nordisk launches in the U.S.
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the…